Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Soler

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
The Journal of Investigative Dermatology|August 21, 2016
Expanding the List of Dysregulated Immunosuppressive Cells in PsoriasisDavid C Soler, Thomas S McCormick
The Journal of Investigative Dermatology|August 17, 2011
The dark side of regulatory T cells in psoriasisDavid C Soler, Thomas S McCormick
Psoriasis (Auckland, N.Z.)|February 2, 2018
Current knowledge on psoriasis and autoimmune diseasesNilmarie Ayala-Fontánez, David C Soler, Thomas S McCormick
Frontiers in Cell and Developmental Biology|December 29, 2022
Targeting TGF-β signaling in the multiple myeloma microenvironment: Steering CARs and T cells in the right directionPriyanka S Rana, David C Soler, Jeries Kort, et al.
Journal of Neuro-Oncology|November 26, 2021
Using chimeric antigen receptor T-cell therapy to fight glioblastoma multiforme: past, present and future developmentsDavid C Soler, Amber Kerstetter-Fogle, Thomas S McCormick, et al.
Scientific Reports|February 13, 2023
Multiple plasma membrane reporters discern LHFPL5 region that blocks trafficking to the plasma membraneDavid C Soler, Angela Ballesteros, Andrew E Sloan, et al.
The Application of Clinical Genetics|February 3, 2016
Case report of individual with cutaneous immunodeficiency and novel 1p36 duplicationAlyn D Hatter, David C Soler, Christine Curtis, et al.
Clinical Immunology (Orlando, Fla.)|August 20, 2013
Psoriasis patients exhibit impairment of the high potency CCR5(+) T regulatory cell subsetDavid C Soler, Hideaki Sugiyama, Andrew B Young, et al.
Biology of Reproduction|May 8, 2009
Expression of transgenic PPP1CC2 in the testis of Ppp1cc-null mice rescues spermatid viability and spermiation but does not restore normal sperm tail ultrastructure, sperm motility, or fertilityDavid C Soler, Suraj Kadunganattil, Shandilya Ramdas, et al.
The Journal of Investigative Dermatology|January 26, 2016
Increased, but Functionally Impaired, CD14(+) HLA-DR(-/low) Myeloid-Derived Suppressor Cells in Psoriasis: A Mechanism of Dysregulated T CellsDavid C Soler, Andrew B Young, Lori Fiessinger, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
The Journal of Investigative Dermatology|August 21, 2016
Expanding the List of Dysregulated Immunosuppressive Cells in PsoriasisDavid C Soler, Thomas S McCormick
The Journal of Investigative Dermatology|August 17, 2011
The dark side of regulatory T cells in psoriasisDavid C Soler, Thomas S McCormick
Psoriasis (Auckland, N.Z.)|February 2, 2018
Current knowledge on psoriasis and autoimmune diseasesNilmarie Ayala-Fontánez, David C Soler, Thomas S McCormick
Frontiers in Cell and Developmental Biology|December 29, 2022
Targeting TGF-β signaling in the multiple myeloma microenvironment: Steering CARs and T cells in the right directionPriyanka S Rana, David C Soler, Jeries Kort, et al.
Journal of Neuro-Oncology|November 26, 2021
Using chimeric antigen receptor T-cell therapy to fight glioblastoma multiforme: past, present and future developmentsDavid C Soler, Amber Kerstetter-Fogle, Thomas S McCormick, et al.
Scientific Reports|February 13, 2023
Multiple plasma membrane reporters discern LHFPL5 region that blocks trafficking to the plasma membraneDavid C Soler, Angela Ballesteros, Andrew E Sloan, et al.
The Application of Clinical Genetics|February 3, 2016
Case report of individual with cutaneous immunodeficiency and novel 1p36 duplicationAlyn D Hatter, David C Soler, Christine Curtis, et al.
Clinical Immunology (Orlando, Fla.)|August 20, 2013
Psoriasis patients exhibit impairment of the high potency CCR5(+) T regulatory cell subsetDavid C Soler, Hideaki Sugiyama, Andrew B Young, et al.
Biology of Reproduction|May 8, 2009
Expression of transgenic PPP1CC2 in the testis of Ppp1cc-null mice rescues spermatid viability and spermiation but does not restore normal sperm tail ultrastructure, sperm motility, or fertilityDavid C Soler, Suraj Kadunganattil, Shandilya Ramdas, et al.
The Journal of Investigative Dermatology|January 26, 2016
Increased, but Functionally Impaired, CD14(+) HLA-DR(-/low) Myeloid-Derived Suppressor Cells in Psoriasis: A Mechanism of Dysregulated T CellsDavid C Soler, Andrew B Young, Lori Fiessinger, et al.
Pageof 2